Plagiarism is alive and well II see. MXAMDUD

New Post Public Reply Private Reply Replies (0) Message Board
Kelt
828

Plagiarism is alive and well II see.



MXAMDUD Monday, 01/17/22 12:16:58 PM
Re: None 0
Post #
387134
of 387134
Since the trial results I have been watching quietly and patiently assessing the situation
and I have not lost my confidence in the ability of IPIX to survive and thrive.

Yes the bashers have dominated the "airwaves" lately with their worn out lines and accusations
but what hasn't changed is the science and the tenacity of the company and management.

We all know that (pardon the politics,mods) the powers that be have obviously been squelching
theraputics in favor of vaccine mandates and passports.We have seen this not only on currently
available products but also in the "slow walking" that has been exerted on trials as well as
the "favoritism" extended to large players.
That's why I was skeptable with the IPIX trial and now their results.

Still,Bril is a major antiviral regardless of skeptics, with massive profit potantial.

Same with B in gastric applications,dermatology,etc.Nothing has changed.
(And don't even think of forgetting Kevetrin)

Hopefully I'm not speaking too soon but I notice NO CHANGES IN MGT.and PERSONNEL/Dr.Degrado/BOD

Why hasn't everyone jumped ship yet?

Then the statement in the last PR:
"As discussed previously, the Company remains focused on developing
Brilacidin as a novel therapy for Inflammatory Bowel Disease (IBD), specifically Ulcerative Colitis,
and also has plans to initiate Phase 3 testing of Brilacidin as an oral rinse treatment for Oral Mucositis
(OM) in head and neck cancer patients. Drug product development is ongoing with specialized Contract
Development and Manufacturing Organizations (CDMOs) responsible for refining the respective Brilacidin
formulation. The IBD and OM clinical indications represent large areas of unmet need, with significant
addressable commercial markets.

Elsewhere, Innovation management is engaged in discussions potentially to acquire rights to new pipeline
assets, as well as to enter into new licensing agreements. The Company plans to provide updates on these
matters as warranted. There is no guarantee, implied or otherwise, that such matters will result
in the execution of definitive agreements"

So Why are all the bashers still here if IPIX is DOA?
Because IPIX will always be a huge threat to the status quo as long as it lives.

That said,I remain optimistic and confident.
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Fraud Lawsuit: Investors' Chance to Step Up

Updated Category News Views 6

Investors Grapple with AST SpaceMobile's Legal Challenges When I hear 'securities fraud lawsuit,' my gut instinct as a trader is to dig deep into the grime and figure out what's lurking beneath. AST SpaceMobile, those folks aiming to shake up the satellite game, have some explaining to do. If you've been holding onto ASTS shares between March 4, 2025, and July 15, 2026,...

Continue Reading
LAZ Parking and indiGOtech's Bold EV Charging Move

Updated Category News Views 0

EV Chargers: The Future Parked Closer? I've been around the block more times than a cabbie in Manhattan rush hour, and let me tell you, when it comes to EVs, folks are still playing catch-up. But here's a kicker—LAZ Parking and indiGOtech have decided they're not gonna wait around. This joint venture of theirs aims to sock some sense into the old condo complex parking...

Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026

Updated Category News Views 0

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Continue Reading
Tumor Ablation Market: Charting a Billion-Dollar Surge

Updated Category News Views 16

Cancer's Unforgiving Climb: Opportunity Amidst Challenge Looking at the current state of the global tumor ablation market, one thing's clear—it's on a sort of upward swing you'd expect trains to make, riding the rails of rising cancer rates and technological advancements. At least that's what the folks at Wissen Research are banking on, projecting a leap to $1.8 billion...

Continue Reading
Purlin's Patent: Transforming Real Estate Deals

Updated Category News Views 0

Purlin's Game-Changer: A Patent in Real Estate Real estate has been chugging along like a stubborn mule, dragging deals through opaque negotiations and haphazard guessing games. Then enters Final Offer from Purlin Enterprises, waving a newly granted patent like a shiny golden ticket to those stuck trading homes in the dark. Leveling the Playing Field with Transparency In...

Continue Reading
Artificial Stone Silicosis: A Silent Threat Unveiled

Updated Category News Views 7

The Harsh Reality Behind Artificial Stone You're slicing into your steak at a fancy dinner, and for a moment, you marvel at the countertop beneath your dish—a smooth, sleek surface that's likely made of artificial stone. But beneath that lustrous facade lurks a silent killer affecting those fabricating these countertops every day. Voices from the Frontline Recently,...

Continue Reading
Navigating Braces vs. Invisalign: Key Considerations

Updated Category News Views 9

Choice Between Braces and Invisalign Isn't Straightforward When you're pondering over whether to go with braces or Invisalign, it ain't just a choice you make lightly over coffee. It's a nuanced decision that hinges on a multitude of factors as highlighted by orthodontic experts Dr. Erik Higginbottom and Dr. Kyle Higginbottom from Easton, MD, featured in HelloNation's...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 11

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 14

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
Spooky Suds: House of Horror Meets El Car Wash

Updated Category News Views 12

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

Continue Reading

Top 5 Most Recently Viewed Articles

LUNGevity's Campaign: Raising Awareness for Lung Cancer

Updated Category News Views 66

LUNGevity Launches Awareness Campaign for Lung Cancer This November, the LUNGevity Foundation is set to launch a crucial campaign in honor of Lung Cancer Awareness Month. The initiative, titled "Anyone with Lungs Can Get Lung CancerSM", aims to shed light on the pressing issues surrounding lung cancer, such as the need for awareness, early screening, and available...

Continue Reading
Best Fundamental Stock Analysis Software for Investors

Updated Category Stocks Views 45

If your process blends fundamentals with technicals (buying strong businesses at good technical setups), you need software that handles both halves of the equation. The best fundamental stock analysis software should at least play nicely with your charting workflow, if not integrate it directly. Finding the right platform saves time and sharpens decisions. The challenge...

Continue Reading
American Assets Trust Provides Key Conference Call Insights

Updated Category News Views 184

Upcoming Earnings Call for American Assets Trust, Inc. American Assets Trust, Inc. (NYSE: AAT), a leading real estate investment trust based in San Diego, is set to share its earnings report for the third quarter of 2025. The company will release the earnings data on a Tuesday evening following the close of the market. Details of the Earnings Report In preparation for the...

Continue Reading
The Heartwarming Story of a Generous $1 Million Contribution

Updated Category News Views 252

Grandparents' Influence and the Power of Wishes This Grandparents Day, the story of Jim and Colleen Clark resonates with hope and love. Their profound impact stemmed from witnessing the joy on their granddaughter Olivia's face when her wish to visit Walt Disney World was fulfilled. Olivia, who bravely faced a battle against a tumor, experienced a magical moment that...

Continue Reading
Atlas Salt's Private Placement: Unlocking Up to $8 Million Investment

Updated Category News Views 145

Introduction to Atlas Salt Inc. Atlas Salt Inc. (TSXV: SALT, OTCQB: REMRF) is making waves in the mining industry with a notable initiative to raise capital. The company is currently undertaking a private placement that could yield gross proceeds of up to $8 million. This funding will be crucial for advancing their ambitious projects, primarily focusing on the development...

Continue Reading